Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nexstim takes on new money man

This article was originally published in Clinica

Executive Summary

Nexstim, the Finnish specialist in navigated brain stimulation, has appointed Mikko Karvinen as chief financial officer, effective 18 August. This is Mr Karvinen’s first foray in the healthcare sector: he was previously CFO at Nordic IT solution provider Innofactor and before that, at SSH Communications Security. His role at Nexstim was formerly held by Janne Huhtala, who was promoted to the role of CEO in January 2013. Privately-held Nexstim is backed by Capricorn Health-tech Fund; Finnish Industry Investment; HealthCap; Ilmarinen; Life Sciences Partners; Lundbeckfond Ventures; and SITRA. The company’s NBT system is CE-marked and US FDA-cleared for brain mapping prior to neurosurgery and is currently being trialled for stroke therapy.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT101840

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel